Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/KS/Topeka
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Topeka, KS

Studies commonly pay $75 to $4,500 per completed study

111 clinical trials are currently recruiting participants within 30 miles of Topeka. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

111studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Topeka right now

Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Crohn Disease Phase 2 Interventional 60 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07483099)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — Topeka, Kansas (1.3 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06528314)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632977)

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Overweight, Obesity Phase 2 Interventional 400 participants sought
Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07589608)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05080673)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 Phase 1, Phase 2 Interventional 92 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04172532)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07097142)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 1,800 participants sought
89bio Clinical Study Site — Topeka, Kansas (1.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — Topeka, Kansas (1.3 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Building Healthy Eating and Self-Esteem Together for University Students

Eating Disorders (Excluding Anorexia Nervosa), Binge-Eating Disorder N/A Interventional 74 participants sought
University of Kansas, Wakarusa Research Facility — Lawrence, Kansas (25.1 mi) · Sponsor: University of Kansas
See eligibility & contact on ClinicalTrials.gov (NCT07060534)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Autoimmune Disease, Crohn Disease Phase 1 Interventional 300 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT03816345)

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Osteoarthritis, Knee, Diabetic Neuropathic Pain Phase 2 Interventional 10,000 participants sought
Cotton O'Neil Clinical Research Center - Central Office — Topeka, Kansas (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT05986292)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Obesity, Type 2 Diabetes Phase 3 Interventional 2,500 participants sought
Cotton O'Neil Diab & Endo Ctr — Topeka, Kansas (1.3 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07564414)

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

Chronic Kidney Disease Phase 3 Interventional 7,000 participants sought
Research Site — Topeka, Kansas (1.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07753993)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma Phase 2 Interventional 152 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04858334)
Actively enrolling

Studies you may be able to join near Topeka

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Topeka

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Cotton O’Neil Clinical Research Center

★ 5.0
and Basement, 823 SW Mulvane St 2nd Floor, Topeka, KS 66606
(785) 354-6000

KMC Research Center

★ 5.0
2200 SW 6th Ave, Topeka, KS 66606
(785) 295-0938
"Alyssa Nash was soooo supportive when answering my questions about a trial I’m thinking about taking part in. She made me feel so much more confident…"
— Natalie Bowman, 5★

Kansas Health Institute

★ 4.4
212 SW 8th Ave #300, Topeka, KS 66603
(785) 233-5443
"Health issues look at for my son"
— raymond foster, 4★

Stormont Vail Hospital - Topeka Campus

★ 2.6
1500 SW 10th Ave, Topeka, KS 66604
(785) 354-6000

Stormont Vail Health Cancer Center

★ 4.0
1414 SW 8th Ave, Topeka, KS 66606
(785) 354-5300
"Told me they didn't feel like doing further testing because it was "too expensive" still sick, still no answers, I wouldn't be surprised if this clin…"
— Malachite Hughes, 1★

Kansas Medical Clinic PA

★ 3.5
2200 SW 6th Ave, Topeka, KS 66606
"The Doctors and nurses were wonderful. The billing department is worthless. Heave BC BS of North Carolina. They it to Ks and refused to reprocess. H…"
— Trish Parre, 5★

Stormont Vail Health

★ 3.0
929 SW Mulvane St Fl 1, Topeka, KS 66606
(785) 354-6000
"Amanda at the front desk was very nice and helpful. Y’all are lucky to have her."
— Andy Smith, 5★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Clinical Research Consultants

★ 4.6
3930 Washington St, Kansas City, MO 64111
(816) 756-1222
"They are the best especially my girl chandrika.she comes with great medical knowledge.i recommend everyone to Check them out."
— Edna Yancy, 5★

Clinical trials in Topeka: what's recruiting

The Topeka area currently has 111 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Topeka, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism6 studies
  • Liver & Kidney6 studies
  • Immune & Skin3 studies

Every listing shows the study phase, the recruiting site and its distance from Topeka, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Topeka

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Topeka participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Topeka pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Topeka safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Topeka?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Topeka?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Topeka.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Topeka typically complete one or two studies per year.

Paid clinical trials near Topeka

Other metros within reach

Olathe, KS1,036 Kansas City, KS1,041 Overland Park, KS1,027 Kansas City, MO1,029 Lincoln, NE154 Wichita, KS163 Omaha, NE600 Tulsa, OK190

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Topeka Bladder Issues Due To Spinal Cord Injury in Topeka All conditions

More of KS

Kansas City1,041 Olathe1,036 Overland Park1,027 Wichita163

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts